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Introduction
The question arises from the need to understand why the use of 
phytotherapy may modulate the immune responses even in the animal 
kingdom as reported by some authors.1 In fact, even if the traditional 
use of herbal medicine products may guarantee efficacy, for very few 
medical plants scientific data on mechanisms of action are available.2 
The term Phytotherapy, derived from the Greek words ‘Phyto’ and 
‘therapy’, was introduced into science by the French physician 
Henri Leclerc (1870-1955) and indicates the therapy practiced 
with medicaments of vegetable origin. A study conducted by the 
World Health Organization had reported that about 80% of world’s 
population relies on traditional medicine. The history of phytotherapy 
is very old and was presumably one of the first therapeutic methods 
undertaken by man. Already in ancient times (since the Egyptian and 
Mesopotamian era), mankind was so fascinated by the therapeutic 
action of plants that for centuries magical and divine properties were 
attributed to them. Later on, humans have learnt by experience and 
observations how to use plants correctly and since the nineteenth 
century the empirical use of plants has been brought back within the 
boundaries of rationality and scientific rigor. But in what way has man 
been using these plants for millenia? These ‘preparations’ of vegetable 
origin have always been used through essentially three administration 
routes: at a lesser extent, by local applications or fumigation, otherwise 
mainly by ingestion. The administration of herbal medicine products 
through the oral route may represent a crucial point, as we will discuss 
below, to explain the efficacy of the traditional medicine. Therefore, 
the text found in the work On Aliment: “In food excellent medication, 
in food bad medication, bad and good relatively”,3 nowadays 
attributed to the Hellenistic period, but in Antiquity (by Galenus in 
particular) erroneously associated with Hippocrates, brings us back to 
why mankind at some point has started to ingest plants or their fruits, 
roots and leaves in order to find in them not only nourishment and 
gratification, but also a therapeutic remedy for its illnesses. Indeed, 
the idea of using plants as medicine treatment was probably born from 
fortuitous observations or from the experiences that many plants used 
in nutrition could also prove to be toxic or poisonous or, better, able 
to improve disorders. However, also Hippocrates from Cos (around 
460 BC-around 375 BC), the father of Western modern medicine, 
knowing that food was closely linked to health and disease, applied 
dietetic measures for the benefit of the sick.4 According to the World 
Health Organization (WHO), every vegetable that contains, in one 
or more of its organs, pharmacologically active substances deserves 
the name of a medicinal plant. The pharmacognosy studies have 
evidenced that the set of these pharmacologically active molecules, 
called phytocomplexes, have the ability to work in synergy with all 
components. A phytocomplex represents the integral pharmacological 
unit of a medical plant. Most of the natural phytocomplexes that exert 
therapeutic actions, once ingested, have shown to act as antioxidants 
(thus reducing the levels of free radicals), as anti-inflammatory 
molecules (thus reducing the risk of chronic inflammatory diseases), as 
anticancer, antimicrobial and immune modulators.1 Living organisms 
such as plants and animals can be considered as a laboratory of 
biosynthesis that must provide not only for their own needs but also 
for their own defense. The afore mentioned phytocomplexes may, 
therefore, represent the set of molecules developed even to protect the 
plant life itself. Indeed, plants as well as animal beings are constantly 
attacked by environmental pathogens that through their entry into 
these living organisms look for their survival in turn.
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Abstract
Phytotherapy, herbal remedies and dietary supplementation are recovering, to 
the present day, more and more attention from the scientific world of the Western 
countries not only in virtue of the antibiotic-resistance emerging problem or of the 
hypersensitivity towards some synthetic molecules typical of the conventional 
medicine, but also because the attention of the consumer/patient is increasingly 
oriented towards the respect for the environment and trusts the green economy as the 
only sustainable policy. However, even if various herbal remedies are recognized as 
antioxidant, antibacterial, anticancer and immunostimulant, the known functioning 
mechanisms of phytocomplexes are still scarse. Furthermore, the in vitro evaluation 
of the mechanisms of action of the single main components are frequently not able to 
reproduce the general effect linked to the intake of the phytocomplex in it’s entirely. 
In this article, hypothesizing that the key of the effectiveness of phytotherapy is due 
to the triggering of common pathways existing between the innate immune system of 
the plant and animal kingdom, it is wanted to try to give a general explanation to the 
functioning principle of phytotherapy in the animal world. In light of this theory, so as 
the route of administration of many vaccines (oral vs injection) has changed in the last 
few years due to the improved knowledge on the operting of mucosal immune system, 
similarly the therapeutic approach of some diseases could also be reconsidered.
Keywords: plant immune system, mucosal immunity, phytotherapy, innate 
immunity,  animal immune system, phytocomplexes, regulatory molecules, humoral
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This struggle for survival permitted a refinement of the means for 
defense and attack both in the plant and in the animal kingdom. Is it 
then possible that the molecular systems that the plant has developed 
for its preservation also elicited immune responses in the animal 
kingdom once ‘the latter’ had ingested/absorbed this set of molecules? 
And if so, which kind of immune responses are they able to give raise 
to?
Vertebrate immune system
Vertebrate immune defense is one of the most complex biological 
phenomena. It consists of two components: the innate and the 
acquired immune systems (humoral and cellular immunity) that 
induce both the systemic and the mucosal immune responses.5‒6 
Furthermore, the immune system may have a large reserve capacity7 
and may reconfigure itself or shift from one type to another to 
optimize its response to different conditions.8 At the gut mucosal 
level, the innate immune response not only represents the first line 
of defense against pathogenic microorganisms, but provides also 
immune-tolerance and the biological signals that instruct the adaptive 
immune system to unleash a response.5‒9 Importantly, it happens 
also at the presence of non-commensal and probiotic bacteria10 or 
of herbal medicine as well.11 The common mucosal immune system 
in vertebrates (comprising the gut-, bronchial- and nasal-associated 
lymphatic tissues) is unique insofar as it can provide both positive 
and negative signals not only for the induction but also regulation of 
immune responses in both the mucosal and systemic compartments 
after oral or nasal antigen challenge.12‒13 Between its defense tools 
against pathogens, the mucosal innate immunity harbors a series of 
physical, chemical and biological innate molecules (i.e. antimicrobial 
peptides) that cooperate with the innate lymphoid cells (ILCs). The 
last, although shares numerous similarities with CD4+ and CD8+ 
T cells, can respond to various stimuli independently of major 
histocompatibility-dependent interactions.14 On the contrary, the 
mucosal adaptive system comprises various antigen-presenting cells, 
like dendritic cells (that cross talk with both innate and adaptive 
systems) and T and B lymphocytes.15 However, in mucosal innate 
immunity remarkable importance has also to be attributed to receptors 
like Toll-like receptors (TLRs), NOD-like receptors, and to RIG-
I-like receptors. The evolutionarily conserved Toll-like receptors 
have been shown to be essential receptors, capable of recognizing 
the highly conserved structural cytosolic pathogen-associated 
microbial patterns (PAMPs) with their common pathogen-associated 
molecules such as lipopolysaccharide and peptidoglycan.16 TLRs 
are differently distributed on almost all mucosal antigen presenting 
cells (macrophages and dendritic cells), B cells, follicle-associated 
epithelium, and M cells17 and, once activated, their signaling pathway 
leads to the expression of numerous genes, activation of transcription 
factors and synthesis of pro-inflammatory and effector cytokines that 
direct the adaptive immune response. Therefore, the process of TLR-
mediated PAMP recognition and the subsequent signaling cascade 
are thought to bridge innate and acquired immunity in the creation 
of protective immune responses against environmental agents. Some 
authors15 hypothesized that at the mucosal level the innate immunity is 
the true regulator of the immune system. Indeed, the mucosal immune 
system is constantly exposed to external environment comprising 
the resident, highly complex mucosal microbiota, antigens of food 
origin or from inhaled air, environmental xenobiotics, and potential 
pathogens and their products. These factors, all together, represent the 
primary force that has driven the development and stimulation of the 
entire immune system during evolution as well as in ontogeny. The 
evolutionary selective pressure of these environmental antigens has 
resulted in the strategic distribution throughout the mucosae of cells 
involved in the uptake, processing, and presentation of antigens and 
in the production of humoral and cellular factors of innate and specific 
immunity.18 Each pattern recognition receptor in innate mucosal 
immunity has the capability to distinguish PAMPs and, unlike the 
adaptive response, it is genetically and evolutionarily conserved, 
highly specialized and heritable, thus making mucosal immunity the 
primary line of defense in almost all mammalian body systems.
Plant immune system
Plants also have a sophisticated immune system that protects them 
from different kinds of pathogen; however, since they lack circulating 
cells, they rely on innate immunity and on systemic signals emanating 
from infection site.19
In this Kingdom, the first line of defense is represented by the 
cell wall with its enzymes, oligosaccharides and endomembrane 
system. Endocytic membrane trafficking from the plasma membrane 
(PM) to the vacuole is an important mechanism that allows the plant 
to respond to environmental changes and to subsequently reinstate 
the homeostatic condition of the cells. Furthermore, in the interface 
between a host cell and a microbial pathogen, could also be present 
unusual membrane structures called extracellular vesicles (EVs), 
whose functions are still to be elucidated. These exosomes could 
play a role in the direct delivery of antimicrobial compounds, or 
deliver RNA molecules that modulate defense signaling pathways 
or regulate cell-to-cell communication.20 Finally, distributed at PM 
level, there are receptors, named transmembrane pattern recognition 
receptors (PRRs) that have a ‘function TLRs-like’ (in animals) and 
that recognize pathogen associated molecular patterns (PAMPs), such 
as bacterial flagellin or fungal chitin or danger associated molecular 
patterns (DAMPs). This type of immune response is called PAMP-
triggered immunity (PTI)19,20and frequently it is strong enough against 
most pathogens to avoid infection. Once there has been the binding 
between PAMPs/DAMPs and PRRs, the plant immune processes 
continue with the endocytosis of the pattern recognition receptors and 
their intracellular trafficking up till destruction. However, when some 
highly adapted pathogens escape this immune response by injecting or 
secreting effector proteins that interfere with the PTI response in host 
cells,21 plants are able to use others immune receptors like nucleotide 
binding domain leucine-rich repeat (NB-LRR) to recognize effectors 
and activate a second level of immune response: the effector-triggered 
immunity (ETI) that acts largely inside the cell19.The PTI and ETI 
pathways share many signaling components (i.e. same co-factors) and 
the difference between these two lies in the ETI’s greater intensity 
of response which often results in the hypersensitive response-
type of programmed cell death (HR-PCD) that physically isolates 
the infection.The latter is also indirectly activated by chloroplasts 
(organelles existing inside the cells) that, during ETI and PTI, 
produce defense signals such as ROS and salicylic acid that induce 
a downstream signaling cascade that activates HR-PCD.20 Pathogen 
effectors from diverse kingdoms are recognized by NB-LRR 
proteins, and activate similar defense responses. Interestingly, plant 
NB-LRR proteins are broadly related to animal CATERPILLER/
NOD/NLR proteins19 that are highly conserved through evolution. 
In cell plants, nanodomains regulate the different mechanisms that 
maintain the signaling specificity and specific defense responses of 
these shared signaling pathways. Since intracellular compartments 
have distinct biological functions in plants, plant cellular homeostasis 
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really depends on the regulation of phytochemicals and subcellular 
environment. Subcellular compartments, endomembrane, 
intracellular trafficking, and communications of intracellular 
organelles (i.e. chloroplasts, stromules) play an important role not 
only in responding to environmental changes (and subsequently in 
reinstating the homeostatic condition of the cells), but also in the 
modulation of physiological changes during immunity. Studies have 
shown that the aforementioned pathogen effectors target just the 
host proteins that function in diverse plant biological processes of 
various subcellular compartments to suppress the pathways involved 
in immune responses.20 However, detection of PAMPs and effectors 
by the plant leads nucleus of the host cell infected to reprogramming 
of the transcriptome to initiate defense responses. Unconventional, 
non-degradative ubiquination has been discovered to play a critical 
role in the regulation/modulation of plant immunity. Ubiquination 
is known to be one of the most abundant protein modification 
processes (protein degradation, but also non-degradative/regulatory 
process) that occurs in the cells; it is highly diverse and complex and, 
between the many types of protein post-translational modification, 
it is unique to eukaryotes.22 Accordingly, a distinct fate for proteins 
involved in different cellular function or their subcellular distribution 
can be regulated through different types of ubiquitin modification. 
Furthermore, ubiquitination can also be reversed, adding more 
complexity to the fate of proteins. To date, ubiquination has been 
shown to regulate nearly all aspects of plant biology,23 including 
immune signaling. It is noteworthy that between the large number of 
ubiquitin enzymes (reflecting their role as the major governing factors 
for appropriate selection of a myriad of cellular substrate proteins to 
be modified by ubiquitin), the role of recently identified RBR-type 
E3s enzyme in plant immunity has not yet been uncovered, although 
this type of E3 ubiquitin ligase is vital to the regulation of human 
and animal immune signaling.24 Furthermore, it has now become 
evident that K63-linked polyubiquitination plays an essential role 
in RETINOIC ACID-INDUCIBLE GENE I (RIG-I)-like receptor 
(RLR)- (that is important in mammalian antiviral innate immunity) and 
TLR-mediated immune signaling. Such K63-linked ubiquitination has 
been found to be essential also to RLR- and TLR-mediated activation 
of the NF-kB pathway.25 Although an understanding of the role and 
underlying mechanistic basis of unconventional ubiquitination in 
plant innate immunity is still at its infant stage, 22 what is clear is that 
the unconventional, non-degradative ubiquitination process is crucial 
in innate and adaptive immune responses of animals and it promises 
to be the same in plants (beside the already verified dominant role of 
conventional ubiquitination in the plant immune network).
Purpose
Returning then to the initial question of why phytotherapy can 
prove effective in modulating the immune responses in the animal 
kingdom it is possible to hypothesize that since the innate immune 
system is highly conserved and, in the animal kingdom, the TLRs and 
NOD receptors of the innate immune system share some features with 
PRRs and NB-LRRs receptors of the plant kingdom (which essentially 
has only innate immunity), the innate immune system of these two 
kingdoms may be sensitive to the same activators and regulatory 
molecules (Figure 1). Indeed, probably because some of the defense 
reactions directly involved in attacking invading pathogens have very 
ancient origins, it has been observed that both plants and animals 
synthesize a wide range of small antimicrobial peptides (for example, 
both produce an oxidative burst via conserved gp91phox NADPH 
oxidases) opening the way to hypothesize and identify similar 
ancestral mechanisms and gene shared by living organisms.26,27
Recently it has been reported that, for instance, polysaccharide 
PRM3 from Rhyncosia minima root enhances immune function 
through TLR4-NF-kB pathway.28 Thus, even if the downstream 
signaling pathways of pattern-recognition receptors in plants and 
animals are usually different,26 it could happen that the activators 
and regulatory molecules of plants are able to trigger the signaling 
pathways of the animal innate immune cells. Newly studies suggested 
strong similarity of defense responses associated with PTI and ETI in 
animals and plants and studies into animal field just recently provided 
some mechanistic insight into ETI in animals.27 
Therefore, such as plants and different animal lineages share 
immune memory characteristics in innate host defense, so it could 
be possible that the molecules produced by the different metabolic 
pathways of the different compartments of a plant cell once triggered 
by pathogens or environmental antigens during PTI and ETI responses 
(i.e. reactive oxygen species, hormones, mitogen-activated protein 
kinase, defensive secondary metabolites called phytoalexins, salicylic 
acid, jasmonic acid and ethylene)26,27 are able to evoke/activate similar 
defensive pathways in the innate immune system in animal kingdom. 
Indeed, the overall structure of microbe-associated molecule 
signaling pathways in plants and animals is similar and in both the 
kingdoms there are transmembrane LRR receptors, such as mitogen-
associated protein kinase (MAPK) signaling cascades, production 
of active oxygen and nitrogen species, calcium fluxes, activation 
of transcription factors and the inducible expression of immune 
effectors. In particular, the components of MAPK signaling cascades 
form a bridge between diverse signal sensors and/or receptors and 
target genes in eukaryotes.26
The phytocomplexes extracted from the different organs of a plant 
represent the summation of the enzymes and molecules contained 
within each single cell. These molecules, expression of a continuous 
production of relevant immune effectors that could be specific or no-
specific regarding the pathogen encountered (expression of sustained 
immune response),27 once introduced in the animal body through the 
phytocomplexes, arrive into a direct contact with the gut associated 
immune system, possibly eliciting an ETI response in mucosal innate 
system of animals.
Indeed, since phyto-derivatives are mainly administered through 
oral route, the type of immune responses that are stimulated in who 
uses phytotherapy have necessarily to pass through the activation of 
the mucosal innate immunity.
The recent discovery in different phylogenetic groups of new 
aspects of immunological memory also in the innate immune system27 
has challenged the paradigm of differential pressure of memory of 
innate vs adaptive immunity: plants upon recognition of infectious 
microbes build immunological memory that enables a boosted defense 
response on re-infection.29
The action of the boosted defense effectors, therefore, is the result 
of concerted actions that simultaneously affects different metabolic 
pathways. For this reason, probably, the effects obtained by using only 
one or few principles extracted from the phytocomplexes are lower 
than those resulting from its use in full.
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Figure 1 Extracellular and intracellular pattern recognition receptor (PRRs) in plants and animals. Plant receptor-like kinases and animal TLRs are similar in 
the structure of the transmembrane  C-terminal LRRs. In both plants and animals, extracellular receptors respond to highly conserved microbe-associated 
molecules such as bacterial flagellin. As with receptor-like kinases and TLRs, the  cytoplasmic plant NBS-LRR pathogen-resistance proteins and animal CLR 
proteins have the same overall tripartite structure with C-terminal LRR and central nucleotide-binding site (NBS) domains; the N-terminal domains, instead, 
change between plants and animals. In plants, the N-terminal domains are usually TIR or coiled-coiled domains; whereas, in animals, it could be Nod1, Nod2 
and NALP3. The overall conservation of the tripartite structure of animal CLR and plant NBS-LRR proteins suggests evolutionary conservation. The ubiquitary 
eukaryotic MAP kinases respond to environmental signals.
1
The cytoplasmic kinases operate different immune responses such as generation of reactive oxygen species (ROS) and ethylene, activation of mitogen-activated 
protein kinase (MAPK) cascades, elevation of intracellular Ca2+ levels, and production and secretion of immune molecules via transcriptional reprogramming30
TIR:  Toll–interleukin 1 receptor domain; CLR or Nod : CATERPILLER or Nod proteins;Modified by Ausubel26 
Conclusion
Typically, the pathological state of a living organism can be 
influenced by the use of a single molecule only in a limited way, since 
it is always polymorphic and expression of alterations of a highly 
complex metabolic network. In phytotherapy, well-chosen plants do 
not suppress symptoms, but stimulate the homeostatic mechanisms 
and immune responses of the organism that, logically, needs of its 
biological times to heal itself. If this hypothesis were confirmed by 
studies aimed at evaluating the effects of phytotherapy on mucosal 
innate immunity15 and, possibly, innate immune memory, just as the 
approach to the route of administration of the vaccine has changed in 
the last few years, the therapeutic approach of some diseases could 
also be reconsidered. In fact, it would be extremely important to verify 
the effects of the release of phytocomplexes directly in the target sites 
to activate the innate immune system. Many secrets in the nature have 
still to be unveiled and a scientific approach to traditional medicine 
will warrant a more thoroughly understanding of the way of action of 
phytocomplexes that plants have made ready to counteract their own 
health problems but that probably can produce the same beneficial 
effects in the animal kingdom by favoring the innate and adaptive 
immune responses and cellular homeostasis.
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